Liise-anne Pirofski
Affiliations: | Yeshiva University, New York, NY, United States |
Area:
Microbiology BiologyGoogle:
"Liise-anne Pirofski"Children
Sign in to add traineeRichardson M. Fleuridor | grad student | 2000 | Yeshiva University |
Robert W. Maitta | grad student | 2004 | Yeshiva University |
Tamika Burns | grad student | 2005 | Yeshiva University |
Kevin R. Fabrizio | grad student | 2009 | Yeshiva University |
Krishanthi S. Subramaniam | grad student | 2009 | Yeshiva University |
Allan J. Guimaraes | grad student | 2010 | Yeshiva University |
Sarah E. Weber | grad student | 2010 | Yeshiva University |
Beza Seyoum Alemu | grad student | 2011 | Yeshiva University |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Focosi D, Franchini M, Pirofski LA, et al. (2021) Is SARS-CoV-2 viral clearance in nasopharyngeal swabs an appropriate surrogate marker for clinical efficacy of neutralising antibody-based therapeutics? Reviews in Medical Virology. e2314 |
Herman JD, Wang C, Loos C, et al. (2021) Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response. Nature Communications. 12: 6853 |
Babb R, Doyle CR, Pirofski LA. (2021) Isolation and Characterization of Human Monoclonal Antibodies to Pneumococcal Capsular Polysaccharide 3. Microbiology Spectrum. e0144621 |
Ozdilek A, Huang J, Babb R, et al. (2021) A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies. Mbio. e0080021 |
Herman JD, Wang C, Loos C, et al. (2021) Functional Antibodies in COVID-19 Convalescent Plasma. Medrxiv : the Preprint Server For Health Sciences |
Casadevall A, Joyner MJ, Pirofski LA. (2020) Neutralizing Antibody LY-CoV555 for Outpatient Covid-19. The New England Journal of Medicine. 384 |
Casadevall A, Joyner MJ, Pirofski LA. (2020) Implications of COVI-19 antibody dynamics for immunity and convalescent plasma therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
Casadevall A, Joyner MJ, Pirofski LA. (2020) SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy. The Journal of Clinical Investigation |
Trevijano-Contador N, Pianalto KM, Nichols CB, et al. (2020) Human IgM inhibits the formation of Titan-like cells in . Infection and Immunity |
Godbout EJ, Madaline T, Casadevall A, et al. (2020) The damage response framework and infection prevention: From concept to bedside. Infection Control and Hospital Epidemiology. 1-5 |